Shore Medical

News: Nationwide PANORAMIC Clinical Trial

Shore Medical is supporting the PANORAMIC clinical trial by helping signpost suitable patients.

The aim of this trial is to find new antiviral treatments for people with COVID-19 that can be taken at home.

To be eligible to join the trial you will need to have a positive test for COVID-19 and symptoms that are likely to be caused by COVID-19, starting in the last 5 days.

The trial is open to people aged 50 or over, or 18-49 years with and underlying health condition.

You can join the trial online, even if you are not currently registered with our practice.  For full details, visit

Clinical Research is a core function of the NHS which helps drive innovation and maintain high standards of patient care. Shore Medical takes part in research commissioned by the NHS which enables us to offer our patients access to new and improved treatments, interventions and medicines which ultimately helps us to develop a wider evidence base across primary care. Dr Alex Todd is our Research Lead at Shore Medical and has completed Good Clinical Practice for Research (GCP) training to ensure we comply with principles set out by the UK policy framework for health and social care research.

The Department of Health set up The National Institute for Health and Research (NIHR) to fund, enable and deliver world-leading health and social care research to improve people’s health and wellbeing and promote economic growth. At a local level the Wessex Clinical Research Network (CRN) provides infrastructure and support to promote high quality research across our area.

There are a number of ways in which you can become involved in research studies within Shore Medical. A doctor or nurse may talk to you about a particular study relevant to your health and ask whether you would be interested in taking part, you may be sent information by SMS or through the post if you are identified as a suitable participant or you may read about studies on our website or in our waiting room.

The studies we undertake have been reviewed by the Wessex CRN and have had ethical approval to ensure they are safe to perform. Your participation is entirely voluntary, and you can withdraw from a research study at any time. Your care will not be affected in any way should you decide not to take part. The consent process ensures you receive clear information about what taking part would involve and you would have the opportunity to ask questions and obtain further details.

Shore Medical work with uMed and as such have a platform data processing agreement in place.  The principle being to allow patients to engage with more academic and commercial research opportunities through their research platform

Shore Medical is also a recognised Participant Identification Centre for Commercial Research Studies and as such work with Participating Organisations including The Adams Practice.

For research queries, please contact:

For further patient information please visit the NHS Health Research Authority website: Patient Data and Research leaflet – Health Research Authority (


Shore Medical takes part in research surveys which are supported by the National Institute of Health Research:

  1. REVIEW Potassium – Healthcare professionals’ approaches to management of hyperkalaemia in patients on RAASi (Portsmouth Hospital)
  2. A national survey of the use of locum doctors in the English NHS (The University of Manchester)
  3. An assessment of healthcare professional’s knowledge and understanding of the management of pruritus in atopic eczema
  4. REDUCE carbon study: randomised control trial to understand whether prescribing choice for inhalers is influenced by knowledge of the carbon footprint


For those who have tested positive for COVID-19 infection in the last 14 days AND are unwell with symptoms – including, but not limited to, high temperature, new, continuous cough, loss or change to smell or taste, sore throat, shortness of breath, general feeling of being unwell, muscle pain, diarrhoea.  The PRINCIPLE trial aims to find treatments that improve symptoms and reduce hospital admissions. The study is currently looking at favipiravir (an antiviral drug) against usual standard NHS care.

Please visit: or call 0800 138 0880 for further information.


Shore Medical is assisting with the COV BOOST study by acting as a Patient Identification Centre (PIC). Their study is looking at seven different COVID-19 vaccines when given as a third dose and is supported by the National Institute for Health Research (NIHR). Adults who are aged 18-30 who have had 2 doses of Pfizer or Moderna at least 3 months apart who have not received a booster may be eligible to take part, further information is available on their website:

Participate – University Hospital Southampton NHS Foundation Trust | COV-Boost (


Shore Medical is assisting with the MULTICATH trial as a patient identification centre (PIC).

MultICath aims to find out whether using a mixture of re-usable catheters and single-use catheters is as safe and acceptable for intermittent catheterisation as using only single-use catheters. If you are identified as being eligible for this study we may contact you by Docmail.

Please see their website for further information:

The MultICath Trial | University of Southampton


Shore Medical is assisting with the BAT NITRATE study as a patient identification centre (PIC)

The study is looking at the effect of inorganic nitrate supplementation on brown fat activation and quantity in people with type 2 diabetes mellitus. This is being run from Bournemouth University.

If you are found to be eligible for this study you may receive a text message signposting you to their study details.

COVID MONITOR – monitoring for side effects after booster vaccine:

Shore Medical is assisting with the COVID MONITOR trial as a patient identification centre (PIC).

A study run by the Drug Safety Research Unit (DSRU). Patients are eligible to register via the website within 48 hours of having their Covid booster. The study then involves completing 7 brief questionnaires over the course of 6 months. This will help build up data about potential side effects from the booster vaccinations. We will also be handing out leaflets for this study during our Shore vaccine clinics.


Shore Medical is assisting with the PANORAMIC trial as a patient identification centre (PIC).

COVID-19 has affected the lives of everybody. We need to find safe and effective treatments that can help people to recover at home, without the need to go to hospital.

Researchers at the University of Oxford – in partnership with the NIHR – are trying to do this right now, and you have an opportunity to help by joining a national priority study called PANORAMIC.

The trial aims to find antiviral treatments that reduce hospital admission and speed-up recovery for people with COVID-19, who are at home and in the early stages of infection.

The first antiviral treatment to be investigated through the trial will be molnupiravir (brand name Lagevrio).

To take part, you will need to have had a positive COVID-19 test result and be experiencing COVID-19 symptoms which started within the last five days. You also need to be aged 50 years and over, or 18 years and over with an underlying health condition, such as asthma.

Taking part is easy. Eligible participants can join online or over the phone from the comfort of your own home. We will courier all the information you need directly to you at home. You will also receive a symptom diary, and you may receive a treatment to take.

Find out more and join the PANORAMIC trial’s volunteers in the search for COVID-19 treatments by visiting:


Shore Medical is assisting with the REGAIN trial as a patient identification centre (PIC).

This REGAIN study aims to find out which of two treatments is better for helping people recover after being in hospital with COVID-19:

  • An online-rehabilitation exercise and recover support group OR
  • A single online session of exercise advice and support

Please visit: REGAIN Trial ( for further information.

This practice is one of over 1900 practices in England and Wales contributing pseudonymised data for national research and surveillance. This data enables continuous monitoring of infections and diseases in the community and is used in ethically approved research. The Oxford RCGP RSC is the main source of information for the UK Health Security Agency (UKHSA) and helps with prediction and management of flu outbreaks and pandemics. Providing pseudonymised data does not affect patients, their care or privacy, however if you no longer wish to allow your information to be used please speak to your GP.